• Disease Overview
  • Signs & Symptoms
  • Causes
  • Affected Populations
  • Disorders with Similar Symptoms
  • Diagnosis
  • Standard Therapies
  • Clinical Trials and Studies
  • References
  • Programs & Resources
  • Complete Report
Select language / seleccionar idioma:

Aquagenic Urticaria

Print

Last updated: 12/5/2024
Years published: 2024


Acknowledgment

NORD gratefully acknowledges Gioconda Alyea, MD (FMG), MS, National Organization for Rare Disorders, for the preparation of this report.


Disease Overview

Summary

Aquagenic urticaria is an extremely rare type of physical urticaria. It is also considered a form of chronic inducible urticaria, triggered by contact with water regardless of temperature. It is characterized by itchy welts (hives) that develop shortly after exposure and typically resolve within an hour or two 1,2,3,4 .

Although the cause is not fully understood, researchers think it may involve a hypersensitivity reaction between water and certain substances in or on the skin 1,2,4 .

Diagnosis involves a water challenge test and treatment includes medication such as antihistamines, topical barriers such as creams and lifestyle adjustments to avoid triggers 1,2.

  • Next section >
  • < Previous section
  • Next section >

Signs & Symptoms

In aquagenic urticaria, hives appear rapidly after direct contact with various sources of water (for example, distilled, tap or saline) regardless of the temperature of the water.

The lesions of aquagenic urticaria are characterized by small, punctate (1 to 3 mm), welts that may occur on all parts of the body, although generally not on the palms of the hands and soles of the feet. Welts appear rapidly within 20 to 30 minutes following exposure to water. Once the water source is removed from the skin, the welts generally fade within 30 to 60 minutes.

Systemic symptoms are rare but have been reported and may be induced by either exposure of the skin to water or by drinking water. Some people do not have any reaction for several hours after an attack. Repeated, short, purposeful exposures to water can lead to a lack of an allergy reaction. Aquagenic urticaria is occasionally associated with other forms of inducible urticaria 4. Aquagenic urticaria presents with specific symptoms after water exposure:1,2,3,4

  • Cutaneous symptoms include:
    • Itchy or painful hives (urticaria) develop within 30 minutes of water contact and usually resolve within 1–2 hours after drying off.
    • Affected areas typically include the neck, chest and arms, though palms and soles are less commonly involved.

Activities such as bathing, swimming, exposure to rain, sweating, or even tears can provoke symptoms.

Unlike other urticarias, aquagenic urticaria rarely causes systemic reactions like anaphylaxis, also known as anaphylactic shock or allergic shock, a severe, life-threatening allergic reaction that can occur within minutes of exposure to an allergen.

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Causes

The exact cause of aquagenic urticaria remains unclear. However, several mechanisms have been proposed:1,2,3

  • Hypersensitivity reaction: Water may interact with specific proteins in the skin to form allergens and these allergens can trigger mast cells which release histamine and other inflammatory mediators, leading to hives and redness.
  • Non-temperature dependent: Unlike cold urticaria, aquagenic urticaria occurs regardless of water temperature, which helps differentiate it from other forms of physical urticaria.
  • Possible genetic component: Although familial cases are rare, there may be a hereditary aspect to the condition, but this remains poorly understood.
  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Affected populations

Aquagenic urticaria is extremely rare. Fewer than 100 cases have been documented worldwide, making aquagenic urticaria one of the rarest types of inducible urticaria 2,3. Symptoms usually appear during adolescence or early adulthood. It affects males and females equally 3.

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Diagnosis

Diagnosis can be suspected in people who develop urticaria from water exposure. The diagnosis is confirmed by a water challenge test.

The water challenge test is done by applying distilled or tap water to the skin for 15–30 minutes. The appearance of hives after the water is removed and the skin dries confirms the diagnosis.

The standard test for aquagenic urticaria is the application of a towel of 35°C (95°F) water or physiologic saline to the upper body for 30 to 40 minutes. The challenge is considered positive if urticaria are present at the test site 10 minutes after removal of the towel/compress 4.

Although water of any temperature can provoke aquagenic urticaria, using ambient-temperature water avoids confusion with cold-induced or local heat urticaria. The upper body is chosen because other areas, such as the legs and arms are affected less commonly in aquagenic urticaria. The affected person should avoid taking antihistamines for several days before doing the test 4.

In some people, rinsing specific areas of the body with water or giving a direct bath and shower have been attempted for diagnosis. Use of these approaches may be required when localized testing using a small water compress is negative, although it should be avoided in people who had severe systemic symptoms in the past.

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Standard Therapies

Treatment

There is no cure for aquagenic urticaria but several strategies can help manage symptoms:

  • Medications:1, 2, 3,4
    • H1 antihistamines: This is the first-line therapy, particularly second-generation options like cetirizine or loratadine. Higher doses may be required for severely affected patients.
    • Omalizumab: This anti-IgE monoclonal antibody (a laboratory-made clone of the body’s antibodies that binds to IgE, a protein antibody produced by the immune system important in allergic reactions) has shown success in treating patients who do not improve.
    • Propranolol at doses of 10 to 40 mg daily was reported to be effective in several people.
    • Stanozolol can be effective in people who have other diseases and in people with aquagenic urticaria who did not improve with oral antihistamines.
    • A low dose of a selective serotonin reuptake inhibitor, in combination with cyproheptadine and methscopolamine, was effective in one case report.
  • Topical barriers:3,4
    • Applying petroleum-based creams or similar occlusive agents before water exposure can reduce symptoms by preventing contact between water and the skin.
  • Phototherapy:2,4
    • Narrowband ultraviolet B (UVB) or PUVA therapy has been used to reduce sensitivity in some patients.
  • Lifestyle modifications:4
    • Avoiding unnecessary water exposure by using wet wipes instead of showers, wearing protective clothing in rain and controlling sweat through temperature regulation may be helpful.

Patients should be educated about their condition, triggers and the importance of carrying antihistamines for prompt treatment of symptoms.

Aquagenic urticaria is typically chronic but usually does not tend to worsen over time. Proper management allows most patients to maintain a good quality of life. In rare cases, symptoms may spontaneously improve 2,3.

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Clinical Trials and Studies

Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.

For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:

Tollfree: (800) 411-1222
TTY: (866) 411-1010
Email: [email protected]

Some current clinical trials also are posted on the following page on the NORD website:
https://rarediseases.org/living-with-a-rare-disease/find-clinical-trials/

For information about clinical trials sponsored by private sources, contact:
www.centerwatch.com

For information about clinical trials conducted in Europe, contact:
https://www.clinicaltrialsregister.eu/

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

References

  1. Abdi P, Diamond C, Stuckless JM. Aquagenic urticaria: presentation, diagnosis and management. BMJ Case Rep. 2024;17(11):e260364. Published 2024 Nov 11. doi:10.1136/bcr-2024-260364
  2. Rujitharanawong C, Kulthanan K, Tuchinda P, Chularojanamontri L, Metz M, Maurer M. A systematic review of aquagenic urticaria-subgroups and treatment options. J Allergy Clin Immunol Pract. 2022;10(8):2154-2162. doi:10.1016/j.jaip.2022.04.033
  3. Hadlow C, James Verheyden M & Wain T. Aquagenic urticaria. November 2019. https://dermnetnz.org/topics/aquagenic-urticaria Accessed Dec 5, 2024.
  4. Dice JP & Gonzalez-Reyes E, Physical (inducible) urticaria. UptoDate. April 25, 2024. https://www.uptodate.com/contents/physical-inducible-urticaria Accessed Dec 5, 2024.
  • < Previous section
  • Next section >

Programs & Resources

RareCare logo in two lines.

RareCare® Assistance Programs

NORD strives to open new assistance programs as funding allows. If we don’t have a program for you now, please continue to check back with us.

Additional Assistance Programs

MedicAlert Assistance Program

NORD and MedicAlert Foundation have teamed up on a new program to provide protection to rare disease patients in emergency situations.

Learn more https://rarediseases.org/patient-assistance-programs/medicalert-assistance-program/

Rare Disease Educational Support Program

Ensuring that patients and caregivers are armed with the tools they need to live their best lives while managing their rare condition is a vital part of NORD’s mission.

Learn more https://rarediseases.org/patient-assistance-programs/rare-disease-educational-support/

Rare Caregiver Respite Program

This first-of-its-kind assistance program is designed for caregivers of a child or adult diagnosed with a rare disorder.

Learn more https://rarediseases.org/patient-assistance-programs/caregiver-respite/

Patient Organizations